Jr. Michael Conick Hanley - May 20, 2024 Form 3 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Chief Operating Officer
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Stock symbol
ANRO
Transactions as of
May 20, 2024
Transactions value $
$0
Form type
3
Date filed
5/22/2024, 05:17 PM
Previous filing
Feb 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ANRO Stock Option (right to buy) May 20, 2024 Common Stock 8K $14.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on each of March 22, 2024, April 22, 2024, May 22, 2024, and June 20, 2024, subject to the Reporting Person's continuous service through each vesting date. The option was granted pursuant to a consulting agreement between the Issuer and the Reporting Person dated July 20, 2023, as amended on February 22, 2024.